Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Azimilide

Azimilide (NE-10064) is a class III antiarrhythmic agent, which works by blocking potassium channels in the heart. Azimilide is a dual blocker of IKs (IC50 = 2.6 μM (2mM [K⁺]ₑ) ) and IKr (IC50 = 1 μM (4 mM [K⁺]) ) . Azimilide blocked HERG channel at 0.1 and 1 Hz with IC50s of 1.4 μM and 5.2 μM respectively. Azimilide also inhibits L-type calcium current (ICa) (IC50 = 17.8 μM) and sodium current (INa) (IC50 = 19 μM) . Azimilide can be used for the study of atrial fibrillation and ventricular fibrillation[1][2][3][4].

Product Specifications

CAS Number

149908-53-2

Product Name Alternative

NE-10064

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Calcium Channel; Potassium Channel; Sodium Channel

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/Azimilide.html

Purity

99.01

Solubility

DMSO : 125 mg/mL (ultrasonic)

Smiles

O=C1N(CCCCN2CCN(C)CC2)C(CN1/N=C/C3=CC=C(C4=CC=C(Cl)C=C4)O3)=O

Molecular Formula

C23H28ClN5O3

Molecular Weight

457.95

Precautions

H302, H315, H319, H335

References & Citations

[1]Busch AE, et al. Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action. Br J Pharmacol. 1998 Jan;123 (1) :23-30.|[2]Yao JA, et al. Azimilide (NE-10064) can prolong or shorten the action potential duration in canine ventricular myocytes: dependence on blockade of K, Ca, and Na channels. J Cardiovasc Electrophysiol. 1997 Feb;8 (2) :184-98.|[3]Fermini B, et al. Use-dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: block of delayed rectifier potassium and L-type calcium currents. J Cardiovasc Pharmacol. 1995 Aug;26 (2) :259-71.|[4]Black SC, et al. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug. J Cardiovasc Pharmacol. 1993 Dec;22 (6) :810-8.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Phase 3

Isoform

Inwardly rectifying potassium channel; L-type calcium channel

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

KCNH2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
K1119406 1.0 µg DNA

KCNH2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

Sign In for Pricing
View Details
OR52P2P AAV siRNA Pooled Vector
35352161 1.0 µg

OR52P2P AAV siRNA Pooled Vector

Sign In for Pricing
View Details
Boc-HyNic-PEG2-N3
HY-133501 1 Each

Boc-HyNic-PEG2-N3

Sign In for Pricing
View Details
Mouse Solute Carrier Family 30, Member 5 (SLC30A5) ELISA Kit
DLR-SLC30A5-Mu-96T 96 Tests

Mouse Solute Carrier Family 30, Member 5 (SLC30A5) ELISA Kit

Sign In for Pricing
View Details
Anti-GNRH2 Antibody
CQA3449-01 30 µL

Anti-GNRH2 Antibody

Sign In for Pricing
View Details
Anti-GNRH2 Antibody
CQA3449-02 50 μL

Anti-GNRH2 Antibody

Sign In for Pricing
View Details